These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 1826616)
1. Interleukin-1 and interleukin-1 antagonism. Dinarello CA Blood; 1991 Apr; 77(8):1627-52. PubMed ID: 1826616 [TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1 in host responses to infectious diseases. Dinarello CA Infect Agents Dis; 1992 Oct; 1(5):227-36. PubMed ID: 1344662 [TBL] [Abstract][Full Text] [Related]
3. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Dinarello CA Int J Tissue React; 1992; 14(2):65-75. PubMed ID: 1399323 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Dinarello CA Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). Conti P; Panara MR; Porrini AM; Gambi D; Barbacane RC; Reale M; Bongrazio M; Dempsey RA Scand J Immunol; 1992 Jul; 36(1):27-33. PubMed ID: 1535451 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Dinarello CA Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757 [TBL] [Abstract][Full Text] [Related]
10. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells. Rambaldi A; Torcia M; Bettoni S; Vannier E; Barbui T; Shaw AR; Dinarello CA; Cozzolino F Blood; 1991 Dec; 78(12):3248-53. PubMed ID: 1835893 [TBL] [Abstract][Full Text] [Related]
11. Dissociation of transcription from translation of human IL-1 beta: induction of steady state mRNA by adherence or recombinant C5a in the absence of translation. Dinarello CA Proc Soc Exp Biol Med; 1992 Jun; 200(2):228-32. PubMed ID: 1533718 [TBL] [Abstract][Full Text] [Related]
12. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Vannier E; Miller LC; Dinarello CA Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284 [TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Granowitz EV; Clark BD; Vannier E; Callahan MV; Dinarello CA Blood; 1992 May; 79(9):2356-63. PubMed ID: 1533322 [TBL] [Abstract][Full Text] [Related]
14. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Granowitz EV; Santos AA; Poutsiaka DD; Cannon JG; Wilmore DW; Wolff SM; Dinarello CA Lancet; 1991 Dec; 338(8780):1423-4. PubMed ID: 1683422 [TBL] [Abstract][Full Text] [Related]
15. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Dinarello CA; Thompson RC Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480 [TBL] [Abstract][Full Text] [Related]
16. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052 [TBL] [Abstract][Full Text] [Related]
17. Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by colony-stimulating factor 1. Matsushime H; Roussel MF; Matsushima K; Hishinuma A; Sherr CJ Blood; 1991 Aug; 78(3):616-23. PubMed ID: 1830498 [TBL] [Abstract][Full Text] [Related]